Coefficient of glucose variation is independently associated with mortality in critically ill patients receiving intravenous insulin

[1]  G. Stoddard,et al.  Moderate glucose control is associated with increased mortality compared with tight glucose control in critically ill patients without diabetes. , 2013, Chest.

[2]  J. Hoekstra,et al.  The effect of diabetes mellitus on the association between measures of glycaemic control and ICU mortality: a retrospective cohort study , 2013, Critical Care.

[3]  Shigeaki Inoue,et al.  Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review , 2013, Critical Care.

[4]  A. Kiss,et al.  Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study , 2013, Critical Care.

[5]  John A Myburgh,et al.  Hypoglycemia and risk of death in critically ill patients. , 2012, The New England journal of medicine.

[6]  J. Krinsley,et al.  The Diabetes Paradox: Diabetes is Not Independently Associated with Mortality in Critically Ill Patients , 2012, Hospital practice.

[7]  G. Van den Berghe,et al.  The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients , 2012, Current opinion in clinical nutrition and metabolic care.

[8]  J. DeVries,et al.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis , 2011, Critical care.

[9]  David Rodbard,et al.  Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability , 2011, Postgraduate medicine.

[10]  P. Shekelle,et al.  Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians , 2011, Annals of Internal Medicine.

[11]  D. M. Keenan,et al.  Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality* , 2010, Critical care medicine.

[12]  J. Krinsley.  Glycemic variability in critical illness and the end of Chapter 1. , 2010, Critical care medicine.

[13]  J. Hans DeVries,et al.  Glucose variability is associated with intensive care unit mortality* , 2010, Critical care medicine.

[14]  C. Sprung,et al.  Insulin-treated diabetes is not associated with increased mortality in critically ill patients , 2010, Critical care.

[15]  I. Douglas,et al.  Diabetes mellitus does not adversely affect outcomes from a critical illness* , 2010, Critical care medicine.

[16]  J. Krinsley.  Glycemic Variability and Mortality in Critically 111 Patients: The Impact of Diabetes , 2009, Journal of diabetes science and technology.

[17]  L. Hung,et al.  Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic Rats , 2009, Journal of Biomedical Science.

[18]  Johan Groeneveld,et al.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.

[19]  Rinaldo Bellomo,et al.  The impact of early hypoglycemia and blood glucose variability on outcome in critical illness , 2009, Critical care.

[20]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[21]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[22]  Rinaldo Bellomo,et al.  Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? , 2009, Critical care.

[23]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[24]  J. Krinsley.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[25]  J. G. van der Hoeven,et al.  Accuracy of bedside glucose measurement from three glucometers in critically ill patients* , 2008, Critical care medicine.

[26]  H. Warner,et al.  An Electronic Protocol for Translation of Research Results to Clinical Practice: A Preliminary Report , 2008, Journal of diabetes science and technology.

[27]  Stanley Lemeshow,et al.  Glucose variability and mortality in patients with sepsis* , 2008, Critical care medicine.

[28]  Michael Bailey,et al.  Blood glucose concentration and outcome of critical illness: The impact of diabetes* , 2008, Critical care medicine.

[29]  Heather Van Duker,et al.  Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[30]  Gordon R Bernard,et al.  A replicable method for blood glucose control in critically Ill patients , 2008, Critical care medicine.

[31]  Alan H. Morris,et al.  Multicenter Validation of a Computer-Based Clinical Decision Support Tool for Glucose Control in Adult and Pediatric Intensive Care Units , 2008, Journal of diabetes science and technology.

[32]  Rolf Rossaint,et al.  Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.

[33]  J. Krinsley.  Glycemic control, diabetic status, and mortality in a heterogeneous population of critically ill patients before and during the era of intensive glycemic management: six and one-half years experience at a university-affiliated community hospital. , 2006, Seminars in thoracic and cardiovascular surgery.

[34]  Miet Schetz,et al.  Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. , 2006, European heart journal.

[35]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[36]  G. Van den Berghe,et al.  Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.

[37]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[38]  Daniel J. Johnson,et al.  Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. , 2005, Mayo Clinic proceedings.

[39]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[40]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[41]  G. Damante,et al.  Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. , 2001, American journal of physiology. Endocrinology and metabolism.

[42]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[43]  A. Marette,et al.  Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[45]  F. G. Benedict,et al.  A Biometric Study of Human Basal Metabolism. , 1918, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.